Atlas Trials

Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)

Clinical trial NCT00406302 · COMPLETED

Trial details

NCT number
NCT00406302
Sponsor
Wolfgang Hilbe
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Non-small-cell Lung
Start date
2007-01-01
Primary completion
2011-06-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.